These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10149980)

  • 21. [Biocompatibility in hemodialysis].
    Guyot C; Petiot D
    Pediatrie; 1988; 43(5):393-6. PubMed ID: 3059310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical implications of hemodialysis membrane biocompatibility.
    Hakim RM
    Kidney Int; 1993 Sep; 44(3):484-94. PubMed ID: 8231020
    [No Abstract]   [Full Text] [Related]  

  • 23. Reduction of mononuclear cytokine production in hemodialysis patients treated with steam-sterilized low-flux polysulphone membranes.
    Aucella F; Vigilante M; Grandone E; Colaizzo D; Margaglione M; Modoni S; Orlandini G; Stallone C
    Int J Artif Organs; 1998 Apr; 21(4):210-5. PubMed ID: 9649062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Citrate compared to low molecular weight heparin anticoagulation in chronic hemodialysis patients.
    Janssen MJ; Deegens JK; Kapinga TH; Beukhof JR; Huijgens PC; van Loenen AC; van der Meulen J
    Kidney Int; 1996 Mar; 49(3):806-13. PubMed ID: 8648924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review of the concept of biocompatibility.
    Schulman G
    Kidney Int Suppl; 1993 Jun; 41():S209-12. PubMed ID: 8320923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytokines and biocompatibility.
    Dinarello CA
    Blood Purif; 1990; 8(4):208-13. PubMed ID: 1964790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of continuous ambulatory peritoneal dialysis on anemia in uremic patients.
    Marcovici O; Boner G; Rosenfeld JB
    Isr J Med Sci; 1983 Jul; 19(7):604-7. PubMed ID: 6885343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biocompatibility of artificial organs: an overview.
    Henderson LW; Chenoweth D
    Blood Purif; 1987; 5(2-3):100-11. PubMed ID: 3304344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adsorption dialysis: from physical principles to clinical applications.
    Aucella F; Gesuete A; Vigilante M; Prencipe M
    Blood Purif; 2013; 35 Suppl 2():42-7. PubMed ID: 23676835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peritoneal dialysis is the therapy of choice for end-stage renal disease patients with hereditary clotting disorders.
    Bajo MA; del Peso G; Jiménez V; Aguilera A; Villar A; Jiménez C; Selgas R
    Adv Perit Dial; 2000; 16():170-3. PubMed ID: 11045286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term complications of dialysis: infection.
    Khan IH; Catto GR
    Kidney Int Suppl; 1993 Jun; 41():S143-8. PubMed ID: 8320909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histamine and serotonin in uremic pruritus: effect of ondansetron in CAPD-pruritic patients.
    Balaskas EV; Bamihas GI; Karamouzis M; Voyiatzis G; Tourkantonis A
    Nephron; 1998; 78(4):395-402. PubMed ID: 9578065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The neutrophil function of uremic patients treated by hemodialysis or CAPD.
    Huttunen K; Lampainen E; Silvennoinen-Kassinen S; Tiilikainen A
    Scand J Urol Nephrol; 1984; 18(2):167-72. PubMed ID: 6463600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Problems of biocompatibility in hemodialysis treatment].
    Bommer J
    Klin Wochenschr; 1986 Sep; 64(18):876-83. PubMed ID: 3534433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuous ambulatory peritoneal dialysis in children: comparison with hemodialysis.
    Baum M; Powell D; Calvin S; McDaid T; McHenry K; Mar H; Potter D
    N Engl J Med; 1982 Dec; 307(25):1537-42. PubMed ID: 6815528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complement activation during extracorporeal therapy: biochemistry, cell biology and clinical relevance.
    Johnson RJ
    Nephrol Dial Transplant; 1994; 9 Suppl 2():36-45. PubMed ID: 8065616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heparin-free hypothermal hemodialysis at 20 degrees C improves biocompatibility.
    Otte KE; Jensen PB; Svendsen P; Gram J; Starklint H; Jørgensen KA
    Blood Purif; 1997; 15(3):200-7. PubMed ID: 9262847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glutathionyl hemoglobin in uremic patients undergoing hemodialysis and continuous ambulatory peritoneal dialysis.
    Takayama F; Tsutsui S; Horie M; Shimokata K; Niwa T
    Kidney Int Suppl; 2001 Feb; 78():S155-8. PubMed ID: 11169002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-permeable membranes and hypersensitivity-like reactions: role of dialysis fluid contamination.
    Bigazzi R; Atti M; Baldari G
    Blood Purif; 1990; 8(4):190-8. PubMed ID: 2085427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of complement in biomaterial-induced inflammation.
    Nilsson B; Ekdahl KN; Mollnes TE; Lambris JD
    Mol Immunol; 2007 Jan; 44(1-3):82-94. PubMed ID: 16905192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.